Prostate-specific membrane antigen-based imaging in prostate cancer: impact on clinical decision making process.

Demirkol M. O. , Acar O., Ucar B., Ramazanoglu S. R. , Saglican Y. , Esen T.

The Prostate, cilt.75, sa.7, ss.748-57, 2015 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 75 Konu: 7
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1002/pros.22956
  • Dergi Adı: The Prostate
  • Sayfa Sayıları: ss.748-57


BACKGROUNDThere is an ongoing need for an accurate imaging modality which can be used for staging purposes, metastatic evaluation, predicting biologic aggresiveness and investigating recurrent disease in prostate cancer. Prostate specific membrane antigen, given its favorable molecular characteristics, holds a promise as an ideal target for prostate cancer-specific nuclear imaging. In this study, we evaluated our initial results of PSMA based PET/CT imaging in prostate cancer.